Angiotensin II Receptor Blockers in the Management of Hypertension in Preventing Cognitive Impairment and Dementia—A Systematic Review

Hypertension is a known risk factor for cognition-related pathologies including dementia. The National Institute of Health and Care Excellence (NICE) guidelines recommend angiotensin (Ang) II receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors (ACEIs) as a first-line treatment for h...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Silva, Elvira, Meor Azlan, Nur Farah, Zhang, Jinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609033/
https://www.ncbi.nlm.nih.gov/pubmed/36297558
http://dx.doi.org/10.3390/pharmaceutics14102123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609033/
https://www.ncbi.nlm.nih.gov/pubmed/36297558
http://dx.doi.org/10.3390/pharmaceutics14102123

Ejemplares similares